Financials
Financial year 2025
Dr. Stéphanie SMET, Radiotherapie-Oncologie from Schilde, company number BE0703949388, closed financial year 2025 with a result of € 214,383 after tax. For that financial year Dr. Stéphanie SMET, Radiotherapie-Oncologie recorded a gross margin of € 290,579 and equity of € 72,922. Compared with financial year 2024, the result moved from € 307,081 to € 214,383. The company is profitable. The buffer shrank hard: equity is 81 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 72,922
▼ 81% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 214,383
▼ 30% vs 2024
Profit after tax over the fiscal year.
€ 348,157
▲ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 521,463 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 77,594
▲ € 67,016 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 23,333
▲ 99% vs 2024
Loans from banks and other lenders, long and short.
€ 77,267
▲ € 64,338 vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 272,315 | € 293,309 | € 412,644 | € 290,579 | ▼ 30% |
| Profit after taxes | € 205,262 | € 215,900 | € 307,081 | € 214,383 | ▼ 30% |
| Equity | € 72,922 | € 72,922 | € 380,002 | € 72,922 | ▼ 81% |
| Total debts | € 321,786 | € 321,192 | € 110,818 | € 467,916 | ▲ € 357,098 |
| Cash | € 281,543 | € 245,789 | € 274,214 | € 348,157 | ▲ 27% |
| Retained profit | € 54,322 | € 54,322 | € 361,402 | € 54,322 | ▼ 85% |
| Dividend | € 508,125 | € 215,900 | € 0 | € 521,463 | |
| Bank debt | € 8,280 | € 12,698 | € 11,721 | € 23,333 | ▲ 99% |
| Balance sheet total | € 394,708 | € 394,113 | € 490,820 | € 540,837 | ▲ 10% |
Key figures of Dr. Stéphanie SMET, Radiotherapie-Oncologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Stéphanie SMET, Radiotherapie-Oncologie?
What happened at Dr. Stéphanie SMET, Radiotherapie-Oncologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 214,383 (▼ 30% vs 2024). Source: NBB ↗
- New establishment in Schilde. KBO
- Stéphanie Smet became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 205,262 profit in 2022 to € 214,383 profit in 2025.
Paid € 303,027 in corporate taxes since 2022.
Best year ever: 2024, with € 307,081 profit.
Paid out € 1.2 million in dividends to the owners in total.
A new publication or filing at Dr. Stéphanie SMET, Radiotherapie-Oncologie? We notify you, reason included.
Follow Dr. Stéphanie SMET, Radiotherapie-OncologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Stéphanie SMET, Radiotherapie-Oncologie is Stéphanie Smet.
Directors
According to the 2025 annual accounts
Stéphanie Smet
Bestuurder
since 2018
Establishments
Establishment units
Physical locations of this company
Eekhoornlaan 32
2970 Schilde
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0703.949.388
- VAT number
- BE 0703.949.388
- Registered office
- Eekhoornlaan 32, 2970 Schilde
- Names & denominations
- Dr. Stéphanie SMET, Radiotherapie-Oncologie · Dr. Stéphanie SMET
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 September 2018
- Peppol
- Active · Active since 24 Nov 2023